Living with Schizophrenia can present significant challenges, both for the individual diagnosed with the disease and for their friends and family.
We are inviting you to take part in the EMPOWER-3 Study, testing an investigational drug for people diagnosed with Schizophrenia.
You may be eligible to participate in the EMPOWER-3 Study if you:
- Are 18 – 65 years old
- Have a diagnosis of Schizophrenia from a doctor
- Have been taking Schizophrenia medication for at least 3 months in the last year
* As a study participant, all study-related medical exams will be provided at no cost to you, including the study drug, and there is no cost to participate in the study.
Sign Up
What happens if I sign up? We will match you to a research study location in your area that needs volunteers diagnosed with Schizophrenia or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if qualified.
If you think you would like to participate in the EMPOWER-3 Study or would like more information, please enter your information below so we can see if you qualify and can contact you about the study. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
About Schizophrenia
Schizophrenia is a serious mental illness that causes disruptions in an individual’s emotional responsiveness, social interactions and thought processes. Acute episodes of psychosis are a hallmark feature of Schizophrenia. During these episodes, individuals may experience a break from reality, leading to impaired thoughts, hallucinations and delusions.1
The exact cause of Schizophrenia is not fully understood, but it is believed to involve a combination of genetic, neurological, and environmental factors. Professional help and ongoing medical treatment can significantly improve both the outcomes and quality of life for those diagnosed with Schizophrenia.2
The EMPOWER-3 Study is looking at how well a new medicine works, if it's safe, and if people can tolerate it. The medicine could potentially help treat Schizophrenia.
Frequently Asked Questions
What is a research study?
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are research studies important?
A research study is the process by which new and innovative medications, interventions and treatments are approved and brought to the market, so people can live happier and healthier lives. Even over-the-counter medications, such as NSAIDs (Nonsteroidal anti-inflammatory drugs), which you may have used to counteract a headache, have gone through the clinical research study process before they were available at your local pharmacy.
What is the purpose of the EMPOWER-3 Study?
The EMPOWER-3 Study is looking at how well a new medicine works to potentially help treat Schizophrenia.
What will the EMPOWER-3 Study involve?
The EMPOWER-3 Study will enroll about 850 people across approximately 120 centers worldwide.
The study will include 13 visits to a study center in your location and one phone call over approximately 13-14 months.
Will I receive compensation?
Compensation for participation is available. You are able to discuss this with the study team when they contact you.
Is there a cost to participate?
There is no cost to participate in the EMPOWER-3 Study. If you qualify, all study-related care will be provided at no cost to you, including the investigational drug.
What else do I need to consider?
The study team will be able to explain more about what the EMPOWER-3 Study will involve , and it is up to you to decide if you want to participate. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the research center?
We match you to a study center within a close travel distance from your home. If we are not currently running the study in your area, with your permission, we will keep you in our database and reach out once a study location becomes available. If, at any time, you decided you no longer want your information stored, you can opt out and we will delete your details.
About the EMPOWER-3 Study
The EMPOWER-3 Study will enroll 850 participants diagnosed with Schizophrenia at approximately 120 study centers worldwide.
Your participation in the study will include 13 visits to a study center in your location and one phone call over approximately 13-14 months.
As a study participant, all study-related care will be provided at no cost to you, including the investigational drug. Participants will be compensated for their time and travel.
The EMPOWER-3 Study is looking at how well a new medicine works, if it's safe, and if people can tolerate it. The medicine could potentially help treat Schizophrenia.
Who can take part in the EMPOWER-3 Study?
You may be eligible to participate in the EMPOWER-3 Study if you:
- Are 18 – 65 years old
- Have a diagnosis of Schizophrenia from a doctor
- Have been taking Schizophrenia medication for at least 3 months in the last year
